isoxazoles has been researched along with Skin Neoplasms in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors | Studies |
---|---|
Jęśkowiak, I; Mączyński, M; Szeląg, A; Wiatrak, B | 1 |
de Castro Araujo, BL; de Melo, AC; de Oliveira, JL; Noguera, WS; Rezende, JFN; Thuler, LCS | 1 |
Ahn, YH; Dinkova-Kostova, AT; Proby, CM; VanHecke, GC; Zhang, Y | 1 |
Bizarro, A; Cincinelli, R; Dallavalle, S; De Cesare, M; Lima, RT; Musso, L; Sousa, D; Vasconcelos, MH; Zuco, V | 1 |
Bouret, AM; Frances, L; Guijarro, J; Leiva-Salinas, Mdel C; Marin, I | 1 |
Kusewitt, DF; Lehman, AM; Nagarajan, P; Oberyszyn, TM; Pruitt, J; Riggenbach, JA; Satoskar, AR; Sielecki, T; Tober, KL | 1 |
Callen, JP; Malone, J; Tidwell, WJ | 1 |
Armuth, V; Berenblum, I | 1 |
Cortez, C; DiGiovanni, J; Harvey, RG; Sawyer, TW | 1 |
9 other study(ies) available for isoxazoles and Skin Neoplasms
Article | Year |
---|---|
Preclinical Study of Immunological Isoxazole Derivatives as a Potential Support for Melanoma Chemotherapy.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line; Cell Movement; Cell Survival; Drug Evaluation, Preclinical; Glycoproteins; Humans; Isoxazoles; Melanoma; Reactive Oxygen Species; Skin Neoplasms | 2021 |
Impact of Non-Steroidal Anti-Inflammatory Drugs on Recurrence and Survival after Melanoma Surgery: A Cohort Study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Female; Humans; Isoxazoles; Kaplan-Meier Estimate; Ketorolac; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Recurrence, Local; Perioperative Period; Piroxicam; Retrospective Studies; Sentinel Lymph Node Biopsy; Skin Neoplasms; Treatment Outcome | 2020 |
Sulfoxythiocarbamate S-4 inhibits HSP90 in human cutaneous squamous cell carcinoma cells.
Topics: Animals; Carcinoma, Squamous Cell; Cells, Cultured; Dose-Response Relationship, Drug; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Keratinocytes; Mice; NIH 3T3 Cells; Resorcinols; Skin Neoplasms; Thiocarbamates | 2020 |
Synthesis and Evaluation of the Tumor Cell Growth Inhibitory Potential of New Putative HSP90 Inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 4; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Isoxazoles; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Pyridones; raf Kinases; Signal Transduction; Skin Neoplasms; Survivin; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Multiple eruptive keratoacanthomas associated with leflunomide.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Carcinoma, Squamous Cell; Drug Eruptions; Female; Humans; Isoxazoles; Keratoacanthoma; Leflunomide; Skin Neoplasms | 2013 |
MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; DNA Damage; Female; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Mice; Morpholines; Neoplasms, Radiation-Induced; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays | 2014 |
Eruptive Keratoacanthomas Associated With Leflunomide.
Topics: Antirheumatic Agents; Drug Eruptions; Female; Humans; Isoxazoles; Keratoacanthoma; Leflunomide; Middle Aged; Skin Neoplasms | 2016 |
Further exploration of stages in carcinogenesis.
Topics: Animals; Caffeine; Cocarcinogenesis; Female; Isoxazoles; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Time Factors; Urethane | 1982 |
Synthesis of the tumorigenic 3,4-dihydrodiol metabolites of dibenz[a,j]anthracene and 7,14-dimethyldibenz[a,j]anthracene.
Topics: Animals; Benz(a)Anthracenes; Chemical Phenomena; Chemistry; Female; Isoxazoles; Mice; Oxazoles; Papilloma; Skin Neoplasms; Structure-Activity Relationship | 1988 |